Real-World Outcome for Newly Diagnosed Patients with Functional High-Risk Myeloma - a Myeloma and Related Diseases Registry Analysis

被引：0
|
作者：
Spencer, Andrew [1 ]
Mollee, Peter [2 ]
Blacklock, Hilary Anne [3 ]
Harrison, Simon [4 ,5 ]
Quach, Hang [6 ]
Ho, P. Joy [7 ]
Spearing, Ruth
Hocking, Jay [8 ]
Augustson, Bradley [9 ]
Prince, H. Miles [10 ]
Moore, Elizabeth M. [11 ]
McQuilten, Zoe
Wood, Erica M. [11 ]
Wellard, Cameron
机构：
[1] Monash Univ, Alfred Hlth, Dept Clin Haematol, Melbourne, Vic, Australia
[2] Princess Alexandra Hosp, Dept Haematol, Brisbane, Qld, Australia
[3] Middlemore Hosp, Auckland, New Zealand
[4] Peter MacCallum Canc Ctr, Clin Haematol, Melbourne, Vic, Australia
[5] Royal Melbourne Hosp, Melbourne, Vic, Australia
[6] St Vincents Hosp, Dept Haematol, Melbourne, Vic, Australia
[7] Royal Prince Alfred Hosp, Inst Haematol, Sydney, NSW, Australia
[8] Box Hill Hosp, Dept Haematol, Melbourne, Vic, Australia
[9] Sir Charles Gairdner Hosp, Dept Haematol, Nedlands, WA, Australia
[10] Epworth Freemasons Hosp, Melbourne, Vic, Australia
[11] Monash Univ, Transfus Res Unit, Melbourne, Vic, Australia
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129431
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
269
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Roundtable: How I treat a newly diagnosed patient with high-risk myeloma
    Kaufman, Jonathan L.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 120 - 124
  • [42] Real-world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database
    Mian, Hira
    LeBlanc, Richard
    Louzada, Martha
    Masih-Khan, Esther
    McCurdy, Arleigh
    Venner, Christopher P.
    Stakiw, Julie
    Kardjadj, Moustafa
    Jimenez-Zepeda, Victor H.
    Sebag, Michael
    White, Darrell
    Aslam, Muhammad
    Song, Kevin
    Reiman, Anthony
    Kotb, Rami
    Gul, Engin
    Reece, Donna
    CANCER MEDICINE, 2023, 12 (04): : 4357 - 4362
  • [43] Propensity Score Matching Analysis to Evaluate Bortezomib/Cyclophosphamide/Dexamethasone and Bortezomib/Thalidomide/Dexamethasone from Real-World Data in Patients with Newly Diagnosed Multiple Myeloma, on Behalf of the Colombian Multiple Myeloma Registry
    Martinez-Cordero, Humberto
    Abello-Polo, Virginia
    Casas, Claudia
    Solano, Maria-Helena
    Espinosa, Daniel
    Perdomo, Ivan
    Reyez, Jheremy
    Osuna, Monica
    Paredes, Viviana
    Figueroa, Jair
    Gomez, Rigoberto
    Jaramillo, Roberto
    Gomez, Alvaro
    Saavedra, Jose-Domingo
    Galvez, Kenny
    Quintero, Guillermo
    Abenoza, Lina
    Gaviria, Lina
    Borjas, Yazmin
    Idrobo, Henry
    Mantilla, William
    Sossa, Claudia
    Salazar, Luis
    Herrera, Juan-Manuel
    Guerrero, Paola
    Guerrero, Alvaro
    Rosales, Carmen
    Munevar, Isabel
    Bermudez, Carlos-Daniel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S444 - S445
  • [44] Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients
    Panopoulou, Aikaterini
    Easdale, Sandra
    Ethell, Mark
    Nicholson, Emma
    Potter, Mike
    Giotas, Asterios
    Woods, Helena
    Thornton, Tracy
    Pawlyn, Charlotte
    Boyd, Kevin D.
    Kaiser, Martin F.
    HEMASPHERE, 2023, 7 (02): : E831
  • [45] Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma
    W I Gonsalves
    S V Rajkumar
    V Gupta
    W G Morice
    M M Timm
    P P Singh
    A Dispenzieri
    F K Buadi
    M Q Lacy
    P Kapoor
    M A Gertz
    S K Kumar
    Leukemia, 2014, 28 : 2060 - 2065
  • [46] Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma
    Gonsalves, W. I.
    Rajkumar, S. V.
    Gupta, V.
    Morice, W. G.
    Timm, M. M.
    Singh, P. P.
    Dispenzieri, A.
    Buadi, F. K.
    Lacy, M. Q.
    Kapoor, P.
    Gertz, M. A.
    Kumar, S. K.
    LEUKEMIA, 2014, 28 (10) : 2060 - 2065
  • [47] Undertreatment of Older Patients with Newly-Diagnosed Multiple Myeloma: Real World Evidence from a Canadian Registry Cohort
    Mian, Hira S.
    Kouroukis, C. Tom
    Pond, Gregory R.
    Seow, Hsien
    Sussman, Jonathan
    BLOOD, 2019, 134
  • [48] Descriptive analysis of multiple myeloma patients in a real-world setting from the Finnish Hematology Registry
    Tskhvarashvili, Giorgi
    Hakkarainen, Katja M.
    Klement, Riho
    Vattulainen, Pia
    Miettinen, Tatu
    Torvinen, Saku
    Lievonen, Juha
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 17 (02):
  • [49] Real World Outcome of High-Risk Multiple Myeloma: An Indian Tertiary Care Centre Experience
    Soni, Anveshika
    Rainchwar, Sujay
    Singh, Reema
    Gupta, Dikshat Gopal
    Tikare, Nakul
    Halder, Rohan
    Palatty, Roy J.
    Sheth, Vipul Sharad
    Agrawal, Narendra
    Bhurani, Dinesh
    Panda, Tribikram
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (02): : e110 - e119
  • [50] Characteristics and Outcomes of Newly Diagnosed Multiple Myeloma Patients, Including High-Risk Cytogenetic and African-American Subgroups, Treated with Daratumumab-based Frontline Regimens in Real-world
    Peter, Voorhees
    Lucio, Gordan N.
    Rohan, Medhekar
    Eric, Chinaeke
    Alex, Fu Z.
    Annelore, Cortoos
    Shuchita, Kaila
    Adriana, Rossi
    Sikander, Ailawadhi
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S21 - S21
12345